129 related articles for article (PubMed ID: 30888031)
1. Association Between Tumor Compartment Volumes, the Incidence of Pretreatment Seizures, and Statin-Mediated Protective Effects in Glioblastoma.
Henker C; Kriesen T; Scherer M; Glass Ä; von Deimling A; Bendszus M; Weber MA; Herold-Mende C; Unterberg A; Piek J
Neurosurgery; 2019 Oct; 85(4):E722-E729. PubMed ID: 30888031
[TBL] [Abstract][Full Text] [Related]
2. Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.
Henker C; Kriesen T; Glass Ä; Schneider B; Piek J
J Neurooncol; 2017 Nov; 135(2):391-402. PubMed ID: 28755324
[TBL] [Abstract][Full Text] [Related]
3. Volumetric assessment of glioblastoma and its predictive value for survival.
Henker C; Hiepel MC; Kriesen T; Scherer M; Glass Ä; Herold-Mende C; Bendszus M; Langner S; Weber MA; Schneider B; Unterberg A; Piek J
Acta Neurochir (Wien); 2019 Aug; 161(8):1723-1732. PubMed ID: 31254065
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
5. Seizures as presenting symptom in patients with glioblastoma.
Dührsen L; Sauvigny T; Ricklefs FL; Mende KC; Schaper M; Matschke J; Goebell E; Westphal M; Martens T
Epilepsia; 2019 Jan; 60(1):149-154. PubMed ID: 30536819
[TBL] [Abstract][Full Text] [Related]
6. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Ellingson BM; Harris RJ; Woodworth DC; Leu K; Zaw O; Mason WP; Sahebjam S; Abrey LE; Aftab DT; Schwab GM; Hessel C; Lai A; Nghiemphu PL; Pope WB; Wen PY; Cloughesy TF
Neuro Oncol; 2017 Jan; 19(1):89-98. PubMed ID: 27580889
[TBL] [Abstract][Full Text] [Related]
7. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.
Henker C; Kriesen T; Fürst K; Goody D; Glass Ä; Pützer BM; Piek J
J Neurooncol; 2016 Feb; 126(3):585-92. PubMed ID: 26603163
[TBL] [Abstract][Full Text] [Related]
8. False-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial Analysis.
Suh CH; Kim HS; Paik W; Choi C; Ryu KH; Kim D; Woo DC; Park JE; Jung SC; Choi CG; Kim SJ
Radiology; 2019 Jun; 291(3):752-762. PubMed ID: 30990380
[TBL] [Abstract][Full Text] [Related]
9. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
10. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
11. Statin use and survival following glioblastoma multiforme.
Gaist D; Hallas J; Friis S; Hansen S; Sørensen HT
Cancer Epidemiol; 2014 Dec; 38(6):722-7. PubMed ID: 25455652
[TBL] [Abstract][Full Text] [Related]
12. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
14. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of reproducibility in MRI quantitative volumetric assessment and its role in the prediction of overall survival and progression-free survival in glioblastoma.
Blomstergren A; Rydelius A; Abul-Kasim K; Lätt J; Sundgren PC; Bengzon J
Acta Radiol; 2019 Apr; 60(4):516-525. PubMed ID: 29966430
[TBL] [Abstract][Full Text] [Related]
16. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.
Telfeian AE; Philips MF; Crino PB; Judy KD
J Exp Clin Cancer Res; 2001 Mar; 20(1):5-10. PubMed ID: 11370829
[TBL] [Abstract][Full Text] [Related]
17. Automated Volumetric Analysis of Postoperative Magnetic Resonance Imaging Predicts Survival in Patients with Glioblastoma.
Krivoshapkin AL; Sergeev GS; Gaytan AS; Kalneus LE; Kurbatov VP; Abdullaev OA; Salim N; Bulanov DV; Simonovich AE
World Neurosurg; 2019 Jun; 126():e1510-e1517. PubMed ID: 30910753
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Ki-67 Index with Volumetric Segmentation and its Value as a Prognostic Marker in Glioblastoma.
Henker C; Kriesen T; Schneider B; Glass Ä; Scherer M; Langner S; Erbersdobler A; Piek J
World Neurosurg; 2019 May; 125():e1093-e1103. PubMed ID: 30790732
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
[TBL] [Abstract][Full Text] [Related]
20. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
Gramatzki D; Kickingereder P; Hentschel B; Felsberg J; Herrlinger U; Schackert G; Tonn JC; Westphal M; Sabel M; Schlegel U; Wick W; Pietsch T; Reifenberger G; Loeffler M; Bendszus M; Weller M
Neurology; 2017 Apr; 88(15):1422-1430. PubMed ID: 28298550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
